FDA Approves First Gene Therapy for Non-Muscle-Invasive Bladder Cancer

MedPage Today) — The FDA has approved nadofaragene firadenovec (Adstiladrin) as the first gene therapy for the treatment of high-risk bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer (NMIBC), the agency announced…
Read More

What's Hot

Foxconn’s January sales surge COVID disruption shaken off

HKETO, Brussels hosts receptions in European cities in celebration of Chinese New Year (with photos)

China’s mega-rich move their wealth, and partying, to Singapore

FDA Approves First Gene Therapy for Non-Muscle-Invasive Bladder Cancer

Study examines medication hesitancy to treat childhood anxiety disorders

WAHED Projects Donates 5M WAHED Coins to Fund Autism Research and Therapy

Novartis Finds Targeted Prostate Cancer Therapy Helps Patients

St John of God Subiaco Hospital pilots Citadel’s oncology IMS

Foxconn’s January sales surge COVID disruption shaken off

HKETO, Brussels hosts receptions in European cities in celebration of Chinese New Year (with photos)

China’s mega-rich move their wealth, and partying, to Singapore

High-speed rail ticket cap to be scrapped

U.S. House plans vote to end foreign air traveler COVID vaccine mandate

Restaurant Realty Company’s Innovative Marketing Program Yields Strong Results

New position statement explicitly supports family, career ambitions

Marie Osmond Plastic Surgery Truth & Facts

Toby Keith Gives Promising Update After Stomach Cancer Battle: ‘We’ll Look at Something Good in the Future’

Jubin Nautiyal meets an accident, suffers multiple injures in ribs and elbow

What's Hot

FDA Approves First Gene Therapy for Non-Muscle-Invasive Bladder Cancer

Related Posts